Vir Biotechnology

VIRNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.841 B

$10.88 +2.64%

Close of 21 Sept 2026

Revenue

$68.6M

#2629 by revenue

Earnings

-$438.0M

Loss-making

Shares outstanding

169,215,958

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#34VericelVCEL$2.03B
#35MesoblastMESO$2.01B
#36Vir BiotechnologyVIR$1.84B
#37Hemab TherapeuticsCOAG$1.77B
#38NovavaxNVAX$1.72B

What if Vir Biotechnology were worth as much as…

Open the what-if tool →

Gold $30.3T

$178,907.80

Per share 16,444× higher

Bitcoin $1.72T

$10,163.37

Per share 934× higher

Nvidia $5.48T

$32,383.81

Per share 2,976× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Vir Biotechnology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.